Clinical Trial Update: Rituximab in Active Ulcerative Colitis [Phase 2, Phase 3]

View source ↗

Summary

A completed Phase 2/3 clinical trial evaluating rituximab for active ulcerative colitis is summarized in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: Royal Liverpool University Hospital | Conditions: Ulcerative Colitis | Phase 2, Phase 3 | Status: COMPLETED